4//SEC Filing
Schenkein David P 4
Accession 0001714899-25-000138
CIK 0001714899other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:26 PM ET
Size
9.1 KB
Accession
0001714899-25-000138
Insider Transaction Report
Form 4
Schenkein David P
Director
Transactions
- Award
Common Stock
2025-06-03+6,037→ 15,257 total - Award
Stock Option (right to buy)
2025-06-03+18,111→ 18,111 totalExercise: $13.93Exp: 2035-06-03→ Common Stock (18,111 underlying)
Holdings
- 31,232(indirect: See footnote)
Common Stock
- 26,232(indirect: See footnote)
Common Stock
Footnotes (5)
- [F1]Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.
- [F2]Includes 6,037 unvested RSUs.
- [F3]The shares are held of record by the David P. Schenkein 2004 Revocable Trust, for which the Reporting Person serves as a trustee.
- [F4]The shares are held of record by the Amy P. Schenkein 2004 Revocable Trust, for which the Reporting Person's spouse serves as a trustee.
- [F5]100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.
Documents
Issuer
Denali Therapeutics Inc.
CIK 0001714899
Entity typeother
Related Parties
1- filerCIK 0001578200
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:26 PM ET
- Size
- 9.1 KB